000 01499nam a2200349Ia 4500
001 EBC3376155
003 MiAaPQ
005 20240121043836.0
006 m o d |
007 cr cn|||||||||
008 980107s1997 dcua sb 000 0 eng d
010 _z 98119250
020 _z0309059763
035 _a(MiAaPQ)EBC3376155
035 _a(Au-PeEL)EBL3376155
035 _a(CaPaEBR)ebr10055149
035 _a(OCoLC)923260976
040 _aMiAaPQ
_cMiAaPQ
_dMiAaPQ
050 4 _aRM666.T784
_bI56 1997
082 0 4 _a615/.782
_221
110 2 _aInstitute of Medicine (U.S.).
_bCommittee on Halcion: An Assessment of Data Adequacy and Confidence.
245 1 0 _aHalcion
_h[electronic resource] :
_ban independent assessment of safety and efficacy data /
_cCommittee on Halcion: An Assessment of Data Adequacy and Confidence, Division of Health Sciences Policy, Division of Neuroscience and Behavioral Health, Institute of Medicine.
260 _aWashington, D.C. :
_bNational Academy Press,
_c1997.
300 _axviii, 158 p. :
_btables.
504 _aIncludes bibliographical references.
533 _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650 0 _aTriazolam.
650 0 _aTranquilizing drugs.
655 4 _aElectronic books.
710 2 _aProQuest (Firm)
856 4 0 _uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3376155
_zClick to View
999 _c201293
_d201293